Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) EBT Margin (2018 - 2026)

TransMedics has reported EBT Margin over the past 8 years, most recently at 52.7% for Q4 2025.

  • For Q4 2025, EBT Margin fell 2941.0% year-over-year to 52.7%; the TTM value through Dec 2025 reached 0.19%, up 9.0%, while the annual FY2025 figure was 0.19%, 9.0% up from the prior year.
  • EBT Margin for Q4 2025 was 52.7% at TransMedics, down from 16.01% in the prior quarter.
  • Over five years, EBT Margin peaked at 370.63% in Q4 2021 and troughed at 239.29% in Q3 2021.
  • A 5-year average of 14.29% and a median of 13.84% in 2022 define the central range for EBT Margin.
  • Biggest five-year swings in EBT Margin: skyrocketed 45324bps in 2021 and later tumbled -39198bps in 2022.
  • Year by year, EBT Margin stood at 370.63% in 2021, then crashed by -106bps to 21.36% in 2022, then skyrocketed by 278bps to 38.07% in 2023, then crashed by -161bps to 23.29% in 2024, then plummeted by -126bps to 52.7% in 2025.
  • Business Quant data shows EBT Margin for TMDX at 52.7% in Q4 2025, 16.01% in Q3 2025, and 22.99% in Q2 2025.